Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company whose SEC filings provide detailed insight into its credit reporting, workforce solutions, and compliance businesses. Through its periodic reports and current reports, Equifax discloses information about its financial condition, results of operations, risk factors, and significant corporate events.
On this page, you can review Equifax’s U.S. Securities and Exchange Commission filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its data, analytics, and cloud technology strategy, global operations across 24 countries, and the performance of areas such as consumer credit information and workforce solutions. Current reports on Form 8-K, such as those filed to announce quarterly financial results, provide timely updates on material events affecting the company.
Investors and analysts can also use this page to access other key documents, including proxy materials related to governance and executive compensation and, where applicable, insider transaction reports on Form 4 that show purchases and sales of Equifax securities by directors and officers. These filings help explain how Equifax manages its role as one of the major U.S. credit bureaus and as a provider of employment verification, AML compliance, and cloud-based analytics solutions.
Stock Titan enhances these filings with AI-powered summaries that highlight important sections and clarify complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new Equifax filings, including 10-Ks, 10-Qs, 8-Ks, and Forms 3 and 4, are available quickly, while AI-generated insights help readers understand the implications of changes in strategy, risk disclosures, and capital allocation for EFX shareholders.
The filing is a Rule 144 notice for EFX reporting 2,455 shares of Common stock tied to a Restricted Stock Vesting event dated 05/06/2026. The broker listed is Fidelity Brokerage Services LLC. The filing also records a prior sale of 2,535 shares on 02/12/2026 for $485,452.50.
Equifax Inc. executive John W. Gamble Jr., EVP, CFO & COO, sold 3,500 shares of common stock in an open-market transaction. The sale occurred at a price of $176.54 per share, and he now directly holds 73,464 shares of Equifax common stock.
The transaction was carried out under a Rule 10b5-1 trading plan that he adopted on November 21, 2025, indicating the sale was pre-arranged. His holdings also include accrued dividend equivalent units tied to restricted stock units through the company’s last dividend payment date.
EFX notice of proposed sale under Rule 144 reporting restricted stock vesting events and a recent disposition. The filing lists vested shares from compensation awards dated 02/11/2025, 05/21/2017, and 02/12/2024, and reports a sale of 4,500 shares on 02/23/2026.
The filing names John Gamble Jr. and lists a broker-dealer Fidelity Brokerage Services LLC with an address in Smithfield, RI.
Equifax Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 9,020,869 shares of Common Stock, representing 7.47% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 9,020,869 shares and sole voting power over 1,195,764 shares. The filing is submitted on behalf of Vanguard Capital Management and affiliated Vanguard investment entities and is signed on 04/29/2026.
Equifax Inc. CEO Mark W. Begor reported a combination of stock option exercises and share sales. On April 24, 2026, he exercised stock options to acquire 37,791 shares of Equifax common stock at $112.46 per share, then sold 37,791 shares in multiple open-market transactions at weighted average prices between about $170.98 and $174.78. The sales were carried out under a Rule 10b5-1 trading plan adopted on October 28, 2025, indicating they were pre-scheduled. Following these transactions, Begor directly holds 307,804 shares of Equifax common stock and has additional indirect holdings through several two-year 2025 grantor retained annuity trusts with 12,333, 38,332, 21,284 and 10,500 shares, respectively.
Equifax Inc. amended its main revolving credit agreement to increase available liquidity and extend maturities. The unsecured revolving credit facility commitments rose from $1.5 billion to $2 billion, and swingline loan capacity increased from $150 million to $200 million.
The amendment also removes a 10 basis point credit spread adjustment on Term SOFR borrowings. The termination date for $1.9 billion of the facility is extended by one year from August 25, 2028 to August 25, 2029, while $100 million still terminates on August 25, 2028. All other terms of the credit agreement remain in effect.
Equifax Inc. reported a Form 144 notice for the proposed sale of 37,791 shares of Common Stock by an affiliate on 04/24/2026. The shares were associated with an option granted 05/04/2018 and the transaction is described as a cash sale on the NYSE.
Equifax Inc. filed a Form S-3 shelf registration statement dated April 21, 2026 to register debt securities, common stock, preferred stock and warrants for sale from time to time. The shelf permits offerings by Equifax and potential future selling securityholders; specific terms will be provided in prospectus supplements.
Equifax Inc. reported record first-quarter 2026 results, with revenue of $1,648.9 million, up 14% year over year and 13% in local currency, exceeding the midpoint of its February guidance by $37 million.
Net income attributable to Equifax rose 29% to $171.5 million, while diluted EPS increased 34% to $1.42. Adjusted EPS was $1.86, up 22%. Workforce Solutions revenue grew 10% to $683.1 million, USIS revenue grew 21% to $605.6 million, and International revenue grew 11% to $360.2 million. The company highlighted strong U.S. mortgage activity, a record 17% new product Vitality Index, and returned $327 million to shareholders through $260 million of share repurchases and $67.1 million in dividends.
For 2026, Equifax reiterated its constant currency revenue growth outlook of about 10%, guiding reported revenue between $6.685 billion and $6.805 billion and adjusted EPS between $8.34 and $8.74, while slightly lifting full-year reported revenue and adjusted EPS for foreign exchange impacts.